The Dish’s Weekly News Wrap Up – May 25, 2012
Just a reminder – please submit presentations and posters to be featured in The Cell Culture Dish’s Scientific Poster Hall. “Canada Oks Osiris Drug; First Stem Cell Therapy,” Reuters Osiris … Continued
Just a reminder – please submit presentations and posters to be featured in The Cell Culture Dish’s Scientific Poster Hall. “Canada Oks Osiris Drug; First Stem Cell Therapy,” Reuters Osiris … Continued
In Part II of our series on “Strategies for Improving Viral Yield in Vaccine Manufacturing,” we will examine the use of bioreactors to improve virus production. With a large number … Continued
Christopher Shen, Kirilynn Svay, Delyan Rusev, Jeffrey Rosenbloom, Dennis Duong, Mukunda Krishna, Matt Croughan Amgen Bioprocessing Center, Keck Graduate Institute, Claremont, CA 91711 Abstract As the workhorse of biopharmaceutical production, … Continued
“Making Gene Mapping Part of Everyday Care,” The Wall Street Journal The cost of mapping a person’s full genetic profile has been dropping quickly. Now, doctors are struggling with a … Continued
In Part I of our series on “Strategies for Improving Viral Yield in Vaccine Manufacturing,” we will look at ways to improve media to increase virus yield and quality. Cell … Continued
Notes from Cell Culture Engineering Conference (CCE XIII) Apr 22-26, 2012 – A guest blog by Steve Pettit, Director Cell Culture, InVitria For the bioproduction of protein therapeutics from CHO … Continued
Notes from Cell Culture Engineering Conference (CCE XIII) Apr 22-26, 2012 A guest blog by Steve Pettit, Director of Cell Culture, InVitria Several presentations at the 2012 CCE XIII demonstrated … Continued
“Cells: Biotech’s Problematic Production Line,” Technology Review MIT The biological therapeutics sold by Amgen and other companies are produced by bacteria or cultured mammalian cells. Even though researchers and companies … Continued
A recent article in Pharma Times titled “US biopharma: nearly 300 vaccines in R&D,” points out that there are currently 300 vaccines either in clinical studies or under review by … Continued
A guest blog by Steve Pettit, Director Cell Culture, InVitria with tables provided by The Dish Dr. Gerhard Gstraunthaler recently presented a seminar with the above title. Gerhard carries a … Continued
“Abbott Petitions FDA to Prevent Humira Biosimilars,” Forbes In a move that is sure to raise debate about the path forward for biosimilars, Abbott Laboratories has filed a citizen’s petition with … Continued